Abstract:Cytochrome P450scc (CYP11A1) can hydroxylate vitamin D3 producing 20S-hydroxyvitamin D3 [20(OH)D3] and 20S,23-dihydroxyvitamin D3 [20,23(OH)2D3] as the major metabolites. These are biologically active acting as partial vitamin D receptor [VDR] agonists. Minor products include 17-hydroxyvitamin D3, 17,20-dihydroxyvitamin D3 and 17,20,23trihydroxyvitamin D3. In the current study we have further analyzed the reaction products from P450scc action on vitamin D3 and have identified two 22-hydroxy-derivatives as products, 22hydroxyvitamin D3 [22(OH)D3] and 20S,22-dihydroxyvitamin D3 [20,22(OH)2D3]. The structures of both of these derivatives were determined by NMR. P450scc could convert purified 22(OH)D3 to 20,22(OH)2D3. The 20,22(OH)2D3 could also be produced from 20(OH)D3 and was metabolized to a trihydroxyvitamin D3 product. We compared the biological activities of these new derivatives to those of 20(OH)D3, 20,23(OH)2D3 and 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3]. 1,25(OH)2D3, 20(OH)D3, 22(OH)D3, 20,23(OH)2D3 and 20,22(OH)2D3 significantly inhibited keratinocyte proliferation in a dose dependent manner. The strongest inducers of involucrin expression (a marker of keratinocyte differentiation) were 20,23(OH)2D3, 20,22(OH)2D3, 20(OH)D3 and 1,25(OH)2D3, with 22(OH)D3 having a heterogeneous effect. Little or no stimulation of CYP24 mRNA expression was observed for all the analogues tested except for 1,25(OH)2D3. All the compounds stimulated VDR translocation from the cytoplasm to the nucleus with 22(OH)D3 and 20,22(OH)2D3 having less effect than 1,25(OH)2D3 and 20(OH)D3. Thus we have identified 22(OH)D3 and 20,22(OH)2D3 as products of CYP11A1 action on vitamin D3 and shown that like 20(OH)D3 and 20,23(OH)2D3, they are active on keratinocytes via the VDR, however, showing a degree of phenotypic heterogeneity in comparison to other P450scc-derived hydroxy-metabolites of vitamin D3. DMD #40071 This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on June 15, 2011 as DOI: 10.1124/dmd.111.040071 at A PE T Jornals on M arch 6, 2022 dm d.aspurnals.org D ow nladed from

Importance of Cytochrome P450-mediated Metabolism in the Mechanism of Action of Vitamin D Analogs.

The vitamin D metabolome: An update on analysis and function

[Biosynthesis of calcifediol and calcitriol: a review]

Cytochrome P450s and the Metabolism of Vitamin A

Discovery and Structural Analysis of Metabolites of Vitamin D3 Lactones

The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism

Vitamin D analogs: Therapeutic applications and mechanisms for selectivity

Novel vitamin D analogs as potential therapeutics: metabolism, toxicity profiling, and antiproliferative activity.

The Burgeoning Role of Cytochrome P450-mediated Vitamin D Metabolites Against Colorectal Cancer

In Vivo Evidence for A Novel Pathway of Vitamin D-3 Metabolism Initiated by P450scc and Modified by Cyp27b1

An Update on Vitamin D Metabolism

Vitamin D: Newer Concepts of Its Metabolism and Function at the Basic and Clinical Level

Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication

Recent Structural Insights into Cytochrome P450 Function

Chemical synthesis, biological activities and action on nuclear receptors of 20S(OH)D3, 20S,25(OH)2D3, 20S,23S(OH)2D3 and 20S,23R(OH)2D3

[Enzyme metabolism and functions in vitamin biosynthesis pathways]

Antioxidant Functions of Vitamin D and CYP11A1-Derived Vitamin D, Tachysterol, and Lumisterol Metabolites: Mechanisms, Clinical Implications, and Future Directions

New aspects of vitamin D metabolism and action — addressing the skin as source and target

Vitamin D Analogs: Mechanism of Action and Therapeutic Applications

Structural diversification of vitamin D using microbial biotransformations

Microsoft Word-31088317-file00